Journals / İstanbul Journal of Pharmacy / 2018 / Cilt: 48 - Sayı: 1

In vitro multiple pharmacological targets of Colutea cilicica Boiss. & Balansa against key enzymes linked to neurodegenerative diseases, diabetes, and hyperpigmentation

Pages
18–24
Publication Date
2018-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings reveal the interesting potential of C. cilicica as a valuable source of phytochemicals that can be used against common noncommunicable diseases, particularly against enzymes involved in neurodegenerative diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Öz DOI: 10.5152/IstanbulJPharm.2018.396764Prevention and treatment of noncommunicable diseases such as neurodegenerative diseases, diabetes, and hyperpigmentation using medicinal plants has attracted increasing attention during the past few decades.
📊
Key Findings & Data:The methanol extracts of C. cilicica vigorously inhibited the activities of acetylcholinesterase and butyrylcholinesterase (1.33 and 0.68 mg galantamine equivalents (GALAE)/g extract, respectively).
💡
Conclusion & Impact:These findings reveal the interesting potential of C. cilicica as a valuable source of phytochemicals that can be used against common noncommunicable diseases, particularly against enzymes involved in neurodegenerative diseases.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Anahtar Kelimeler Colutea cilica · Alzheimer’s disease · diabetes mellitus

Özet

Öz DOI: 10.5152/IstanbulJPharm.2018.396764Prevention and treatment of noncommunicable diseases such as neurodegenerative diseases, diabetes, and hyperpigmentation using medicinal plants has attracted increasing attention during the past few decades. In this study, Colutea cilicica Boiss. & Balansa extracts (ethyl acetate, methanol, and water) were evaluated against key enzymes involved in neurodegenerative diseases, diabetes, and hyperpigmentation. The antioxidant (free radical scavenging, reducing power, β-carotene/linoleic acid, and phosphomolybdenum) and metal chelation properties were also investigated. The methanol extracts of C. cilicica vigorously inhibited the activities of acetylcholinesterase and butyrylcholinesterase (1.33 and 0.68 mg galantamine equivalents (GALAE)/g extract, respectively). It was observed that C. cilicica extracts possessed a higher inhibitory potential for α-glucosidase (2.71–1.23 mmol acarbose equivalents (ACAE)/g extract) than that for α-amylase (0.57–0.12 mmol ACAE/g extract). The water extract of C. cilicica showed potent radical scavenging capacity against DPPH (2, 2-diphenyl-1-picrylhydrazyl) and ABTS (2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (42.46 and 57.70 mg trolox equivalents (TE)/g extract, respectively). Phytochemical determination showed that C. cilicica water extract (17.26 mg rutin equivalents (RE)/g extract) was rich in flavonoids compared with ethyl acetate and methanol extracts (2.78 and 2.83 mg RE/g extract, for the respective extracts). These findings reveal the interesting potential of C. cilicica as a valuable source of phytochemicals that can be used against common noncommunicable diseases, particularly against enzymes involved in neurodegenerative diseases.

🔖

Cite This Article

UYSAL, Ş., CEYLAN, R., AKTUMSEK, A., GÜLER, G. Ö., PİCOT, C., ZENGİN, G., MAHOMOODALLY, M. F. (2018). In vitro multiple pharmacological targets of Colutea cilicica Boiss. & Balansa against key enzymes linked to neurodegenerative diseases, diabetes, and hyperpigmentation. İstanbul Journal of Pharmacy, Cilt: 48 - Sayı: 1, 18–24. https://ajindex.com/articles/41778

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ademiluyi AO, Oboh G (2013). Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (alpha-amylase and alpha-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp Toxicol Pathol 65(3): 305-309.
  2. Ahmed F, Ghalib RM, Sasikala P, Ahmed KKM (2013). Cholinesterase inhibitors from botanicals. Pharmacogn Rev 7(14): 121-130.
  3. Al-Rimawi F, Rishmawi S, Ariqat SH, Khalid MF, Warad I, Salah Z (2016).
  4. Anticancer Activity, Antioxidant Activity, and Phenolic and Flavonoids Content of Wild Tragopogon porrifolius Plant Extracts. J Evid Based Complementary Altern Med 2016: 1-7
  5. Amadoruge PC, Barnham KJ (2011). Alzheimer’s disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling. Int J Alzheimers Dis 2011: 1-9. Botić T, Defant A, Zanini P, Žužek MC, Frangež R, Janussen D, Kersken D, Knez Ž, Mancini I, Sepčić K (2017). Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors. Eur J Med Chem 136: 294-304.
  6. Butterfield DA, Reed T, Newman SF, Sultana R (2007). Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment. Free Radic Biol Med 43(5), 658-677.
  7. Cespedes CL, Balbontin C, Avila JG, Dominguez M, Alarcon J, Paz C, Burgos V, Ortiz L, Peñaloza-Castro I, Seigler DS. (2017). Inhibition on cholinesterase and tyrosinase by alkaloids and phenolics from Aristotelia chilensis leaves. Food Chem Toxicol 109: 984-995.
  8. Chigayo K, Mojapelo PEL, Mnyakeni-Moleele S, Misihairabgwi JM (2016). Phytochemical and antioxidant properties of different solvent extracts of Kirkia wilmsii tubers. Asian Pac J Trop Biomed 6(12): 1037-1043.
  9. Coomber R, Alshameeri Z, Masia F, Mela F, Parker MJ (2017). Hip fractures and Parkinson’s disease: a case series. Injury 48: 2730-2735.
  10. Davis P (1997). Flora of Turkey and the East Aegean Islands. (Vol. 3): Edinburgh Univ. Press,
  11. Edinburgh. Ellis JM, Fell MJ (2017). Current approaches to the treatment of Parkinson’s Disease. Bioorg Med Chem Lett 18: 4247-4255.
  12. Eser F, Altundag EM, Gedik G, Demirtas I, Onal A, Selvi B (2017). Anti-inflammatory effect of D-pinitol isolated from the leaves of Colutea cilicica Boiss et Bal. on K562 cells. Turk J Biochem 42(4): 445-450. García-Blanco A, Baquero M, Vento M, Gil E, Bataller L, Cháfer-Pericás C (2017). Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease